Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : OmniCorder Technologies, Inc. (OMCT) -- Ignore unavailable to you. Want to Upgrade?

To: RikRichter who wrote (45)	8/5/2004 7:21:24 PM
From: Mahatmabenfoo	Respond to of 63

Ah, Rik, holding on to such a fragile reed of this press release. Let me teach you how to read it. > OMCT: Positive Data re BioscanIR(R) System Published > By generating maps of these changes the researchers were > able to distinguish between healthy and cancerous breast so 4 years after they started sales, they're still trying to prove it works?!! There's no statement about: - economics compared with other systems - accuracy compared with other systems Why do you think there have been no sales for 4 years? And now the company has very little staff to even try to make improvements. This company is trying to take off the shelf military equipment and use it in medicine. That doesn't work. Even if the tech was custom designed for medicine it might not work. As 4 years of NOoooooooooooo sales suggests. - Charles